EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Recognition of SARS-CoV-2 Mpro Inhibitors: Insights from Cheminformatics and Quantum Chemistry

Adedapo Olosunde iD, Xiche Hu

Molecules · 15.05.2025 · 30 (10) · 2174

DOI: 10.3390/molecules30102174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 15.05.2025. Verfasst von Adedapo Olosunde und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Toledo, Toledo, OH 43606, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, Coronavirus 3C Proteases, Cheminformatics, Antiviral Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The SARS-CoV-2 main protease (Mpro), essential for viral replication, remains a prime target for antiviral drug design against COVID-19 and related coronaviruses. In this study, we present a systematic investigation into the molecular determinants of Mpro inhibition using an integrated approach combining large-scale data mining, cheminformatics, and quantum chemical calculations. A curated dataset comprising 963 high-resolution structures of Mpro–ligand complexes—348 covalent and 615 non-covalent inhibitors—was mined from the Protein Data Bank. Cheminformatics analysis revealed distinct physicochemical profiles for each inhibitor class: covalent inhibitors tend to exhibit higher hydrogen bonding capacity and sp3 character, while non-covalent inhibitors are enriched in aromatic rings and exhibit greater aromaticity and lipophilicity. A novel descriptor, Weighted Hydrogen Bond Count (WHBC), normalized for molecular size, revealed a notable inverse correlation with aromatic ring count, suggesting a compensatory relationship between hydrogen bonding and π-mediated interactions. To elucidate the energetic underpinnings of molecular recognition, 40 representative inhibitors (20 covalent, 20 non-covalent) were selected based on principal component analysis and aromatic ring content. Quantum mechanical calculations at the double-hybrid B2PLYP/def2-QZVP level quantified non-bonded interaction energies, revealing that covalent inhibitors derive binding strength primarily through hydrogen bonding (~63.8%), whereas non-covalent inhibitors depend predominantly on π–π stacking and CH–π interactions (~62.8%). Representative binding pocket analyses further substantiate these findings: the covalent inhibitor F2F-2020198-00X exhibited strong hydrogen bonds with residues such as Glu166 and His163, while the non-covalent inhibitor EDG-MED-10fcb19e-1 engaged in extensive π-mediated interactions with residues like His41, Met49, and Met165. The distinct interaction patterns led to the establishment of pharmacophore models, highlighting key recognition motifs for both covalent and non-covalent inhibitors. Our findings underscore the critical role of aromaticity and non-bonded π interactions in driving binding affinity, complementing or, in some cases, substituting for hydrogen bonding, and offer a robust framework for the rational design of next-generation Mpro inhibitors with improved selectivity and resistance profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Coronavirus 3C ProteasesCheminformaticsAntiviral AgentsProtease InhibitorsHydrogen BondingQuantum TheoryHumansCOVID-19 Drug TreatmentLigandsProtein BindingCOVID-19

Stichwörter der Autor:innen

CH–π interactionsSARS-CoV-2 main protease (Mpro)covalent and non-covalent inhibitorshydrogen bondingmolecular recognitionquantum mechanicsrational drug designπ–π stacking interactions

Substanzen

Coronavirus 3C ProteasesAntiviral AgentsProtease Inhibitors3C-like proteinase, SARS-CoV-2Ligands

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of Toledo, Toledo, OH 43606, USA.

ORCID-Profile: Adedapo Olosunde

Zitieren

APA

Olosunde, A., & Hu, X. (2025). Molecular Recognition of SARS-CoV-2 Mpro Inhibitors: Insights from Cheminformatics and Quantum Chemistry. Molecules, 30(10), 2174. https://doi.org/10.3390/molecules30102174

Vancouver

Olosunde A, Hu X. Molecular Recognition of SARS-CoV-2 Mpro Inhibitors: Insights from Cheminformatics and Quantum Chemistry. Molecules. 2025;30(10):2174. doi:10.3390/molecules30102174

BibTeX
@article{Olosunde2025,
  author = {Olosunde, Adedapo and Hu, Xiche},
  title = {Molecular Recognition of SARS-CoV-2 Mpro Inhibitors: Insights from Cheminformatics and Quantum Chemistry},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {10},
  pages = {2174},
  doi = {10.3390/molecules30102174}
}
Kostenlos starten →